High prevalence of genetic disorders, nervous system disorders along with the advancement in biotechnology field is the major factor behind the growth of biologics drug discovery market. However, shift from traditional methods to personalized drug discovery is hindering the global biologics drug discovery market.

The major driving forces behind the growth biologics drug discovery market are the huge investments by pharmaceutical companies, diverse diseases like cancer, Parkinson’s and Alzheimer’s, rising geriatric population, increasing healthcare expenditure and well trained personnel. The global biologics drug discovery market size is projected to reach USD 140.9 billion by 2024 at the CAGR of 12% over the forecast period. High throughput screening is widely adopted drug discovery technology owing to the market share of almost 40% in global biologics drug discovery market. Geographically, APAC holds the promising market for biologics drug discovery due to high adoption rate of new technology, aggressive investment by pharma industries and favorable government policies. Gone are the times when drugs are designed to target one particular molecule, now a better way to treat a complex diseases like cancer and cardiovascular diseases to aim for several targets at once. In the coming future ‘magic bullets’ drugs will be designed to hit multiple targets, means drugs will be less picky about their molecular targets.

Request for TOC@ https://www.goldsteinresearch.com/toc-request/global-biologics-drug-discovery-market-outlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024

Market Segmentation
• By Technology
o Q-PCR
o DNA Microarrays
o Protein Microarrays
o High-throughput screening
o Mass Spectrometry
o Gel Electrophoresis
o Chromatography
o Protein and Nucleic Acid Isolation
o Other technologies
• By End User
o Outsourcing (Contract Research Organization)
o Insourcing (Within the Organization)
• By Geography
o North America (US, Canada)
o Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe)
o Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa)
o Latin America (Brazil, Mexico and Rest of Latin America)
o Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific)
o Rest of the World

“Global Biologics Drug Discovery Market Outlook 2024” contains detailed overview of the global biologics drug discovery market in terms of market segmentation by technology and end user.
Further, for the in-depth analysis, biologics drug discovery market report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Sacle) analysis, Porter’s five force model and SWOT analysis.

Global biologics drug discovery market report also provides competitive outlook for some of the major players which includes profiling of companies such as Abbott Laboratories, Inc., Affymetrix Inc., Agilent Technologies, Inc., Bayer Healthcare AG, GE Healthcare Ltd., Albany Molecular Research Inc., Arqule Inc., Astrazeneca plc, Novartis AG, Luminex Corporation, and Molecular Discovery Ltd. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.

Overall, the report represents comprehensive synopsis on the global biologics drug discovery market trends that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Browse full market report@ https://www.goldsteinresearch.com/report/global-biologics-drug-discovery-market-outlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024

About Goldstein Research
Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Our analysts working on latest healthcare industry market reports to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.

Send Us Sample Request@ https://www.goldsteinresearch.com/request-sample/global-biologics-drug-discovery-market-outlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024

Contact for more Info:
Mark Twain
(Global Sales Head)
USA: + 1-646-568-7747
Canada: +1-437-886-1181
UK: +44-203-318-6627
[email protected]
www.goldsteinresearch.com